{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:40:23Z","timestamp":1789371623471,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.vaccine.2012.10.118","type":"journal-article","created":{"date-parts":[[2012,11,12]],"date-time":"2012-11-12T17:04:42Z","timestamp":1352739882000},"page":"559-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep"],"prefix":"10.1016","volume":"31","author":[{"given":"John C.","family":"Morrill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Laughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandadeva","family":"Lokugamage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sbrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Weise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Garry","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.10.118_bib0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2460\/javma.234.7.883","article-title":"Rift Valley fever virus","volume":"234","author":"Bird","year":"2009","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0010","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.12.19160-en","article-title":"International network for capacity building for the control of emerging viral vector-borne zoonotic diseases: ARBO-ZOONET","volume":"14","author":"Ahmed","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0015","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1089\/vbz.2010.0245","article-title":"The status of Rift Valley fever in animals in Saudi Arabia: a mini review","volume":"11","author":"Al-Afaleq","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0020","first-page":"98","article-title":"Twenty years of the presence of Aedes albopictus in Italy \u2013 from the annoying pest mosquito to the real disease vector","volume":"2","author":"Marco Di Luca","year":"2011","journal-title":"Eur Infect Dis"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature09575","article-title":"Impacts of biodiversity on the emergence and transmission of infectious diseases","volume":"468","author":"Keesing","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4269\/ajtmh.2012.11-0450","article-title":"Relationship of climate, geography, and geology to the incidence of Rift Valley Fever in Kenya during the 2006\u20132007 outbreak","volume":"86","author":"Hightower","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.2010.09-0289","article-title":"Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006\u20132008 and possible vector control strategies","volume":"83","author":"Anyamba","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0040","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1469-0691.2010.03441.x","article-title":"The global burden of bacterial and viral zoonotic infections","volume":"17","author":"Christou","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000149174","article-title":"Bunyaviridae","volume":"14","author":"Bishop","year":"1980","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0055","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/vir.0.035105-0","article-title":"Recent advances in the molecular and cellular biology of bunyaviruses","volume":"92","author":"Walter","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0060","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1128\/JVI.79.18.12106-12111.2005","article-title":"Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment","volume":"79","author":"Ikegami","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2007.01.046","article-title":"Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease","volume":"362","author":"Bird","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0070","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1128\/JVI.00476-06","article-title":"NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture","volume":"80","author":"Won","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.virol.2006.09.035","article-title":"The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection","volume":"359","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0080","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis","volume":"81","author":"Won","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0085","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/jvi.62.3.826-833.1988","article-title":"Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression","volume":"62","author":"Kakach","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0090","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0042-6822(89)90442-X","article-title":"Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation","volume":"170","author":"Kakach","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virol.2006.08.002","article-title":"Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins","volume":"357","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0105","doi-asserted-by":"crossref","first-page":"e1000287","DOI":"10.1371\/journal.ppat.1000287","article-title":"Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation","volume":"5","author":"Ikegami","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0115","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs","volume":"75","author":"Bouloy","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0120","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/JVI.02148-08","article-title":"NSs protein of Rift Valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase","volume":"83","author":"Habjan","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0125","first-page":"197","article-title":"Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters","volume":"92","author":"Niklasson","year":"1984","journal-title":"Acta Pathol Microbiol Immunol Scand C"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0130","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill","year":"1987","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0135","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0140","series-title":"Rift Valley Fever workshop","article-title":"Rift Valley fever MP-12 vaccine: a university, government, & industry collaborative development","author":"Bettinger","year":"2009"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0145","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking NSs gene, and expression of a foreign gene","volume":"80","author":"Ikegami","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0921-4488(00)00139-5","article-title":"Prenatal development of ovine fetus","volume":"38","author":"Mufti","year":"2000","journal-title":"Small Rumin Res"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0921-4488(95)00709-1","article-title":"Foetal age estimation in sheep and goats","volume":"19","author":"Sivachelvan","year":"1996","journal-title":"Small Rumin Res"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0160","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/JVI.01702-06","article-title":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor","volume":"81","author":"Tseng","year":"2007","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.10.118_bib0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"Morrill","year":"1991","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2012.10.118_bib0170","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2460\/ajvr.1987.48.07.1138","article-title":"Enzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera","volume":"48","author":"Meegan","year":"1987","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2012.10.118_bib0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0923-2516(89)80086-X","article-title":"Rift Valley fever among domestic animals in the recent West African outbreak","volume":"140","author":"Ksiazek","year":"1989","journal-title":"Res Virol"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0180","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/S0264-410X(03)00131-2","article-title":"Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in Rhesus monkeys","volume":"21","author":"Morrill","year":"2003","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2012.10.118_bib0185","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","article-title":"Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"issue":"10","key":"10.1016\/j.vaccine.2012.10.118_bib0190","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0195","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/jrf.0.0760851","article-title":"Maternal and embryonic factors associated prenatal loss in mammals","volume":"76","author":"Wilmut","year":"1986","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.theriogenology.2008.04.018","article-title":"Infectious causes of embryonic and fetal mortality","volume":"70","author":"Givens","year":"2008","journal-title":"Theriogenology"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(90)90096-5","article-title":"Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine","volume":"8","author":"Saluzzo","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.10.118_bib0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1743-422X-6-125","article-title":"Development of a RVFV ELISA that can distinguish infected from vaccinated animals","volume":"6","author":"McElroy","year":"2009","journal-title":"Virol. J."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:19:18Z","timestamp":1759400358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12015964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0264410X12015964"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.118","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}